sign in
join free
verified
Ordinary
Chengdu VACURE Biotechnology Co., Ltd.
verified
Chengdu VACURE Biotechnology Co., Ltd.
Sichuan,China
Chengdu VACURE Biotechnology Co., Ltd.
Sichuan,China
verified
Ordinary Member
Chengdu VACURE Biotechnology Co., Ltd.
favorite supplier
verified
Ordinary Member
Chengdu VACURE Biotechnology Co., Ltd.
Sichuan,China
Scan QR code
Access to mobile station
Chengdu VACURE Biotechnology Co., Ltd.
Chengdu VACURE Biotechnology Co., Ltd. was established in Chengdu, Sichuan in 2017. It was jointly founded by experts from the Thousand Talents Program of Sichuan Province, Chengdu Rongpiao Program experts, and a number of doctors and senior technical experts in the in vitro diagnostic industry.
VACURE Biotech currently has a team of 600+ people, including 15 doctors and 90+ masters, covering core functional sectors such as R&D, production, marketing, and sales, and focuses on creating affordable, accurate and intelligent on-site rapid detection solutions for acute and chronic diseases for the majority of small and medium-sized hospitals, clinical departments of tertiary hospitals, private hospitals and other medical institutions.
Based on three core technology of the patented flow capture microfluidic chip, time-resolved fluorescent Immunoassay TRFIA, nanomaterial inkjet freeze-dried,VACURE Biotech is committed to the research and development, production and sales of intelligent point-of-care testing (POCT) products in the field of in vitro diagnosis (IVD), providing innovative, convenient, accurate and best-cost POCT diagnostic products and Professional services.
R&D
Most of the R&D team members are more than 270. All the members are from global well-known research institutions or companies like Alere.
Workshop
The workshop covers an area of 18500 square meters.
The aseptic purification workshop meeting GMP standard:12000 square meters.
Chengdu Vacure Biotechnology Co., Ltd. has four subsidiary companies in China:
1. Hunan Kangxin Biotechnology: for Microfludic FIA production.
2. Sichuan Vacure Prelab Biotechnology: for Microfludic DISKFLU production.
3. Hunan Narui New Material Technology: for Antibody, Antigen, Micorspheres production.
4. Henan VACURE Biotechnology: for RT-PCR and POCT PCR production.
VACURE Biotech currently has a team of 600+ people, including 15 doctors and 90+ masters, covering core functional sectors such as R&D, production, marketing, and sales, and focuses on creating affordable, accurate and intelligent on-site rapid detection solutions for acute and chronic diseases for the majority of small and medium-sized hospitals, clinical departments of tertiary hospitals, private hospitals and other medical institutions.
Based on three core technology of the patented flow capture microfluidic chip, time-resolved fluorescent Immunoassay TRFIA, nanomaterial inkjet freeze-dried,VACURE Biotech is committed to the research and development, production and sales of intelligent point-of-care testing (POCT) products in the field of in vitro diagnosis (IVD), providing innovative, convenient, accurate and best-cost POCT diagnostic products and Professional services.
R&D
Most of the R&D team members are more than 270. All the members are from global well-known research institutions or companies like Alere.
Workshop
The workshop covers an area of 18500 square meters.
The aseptic purification workshop meeting GMP standard:12000 square meters.
Chengdu Vacure Biotechnology Co., Ltd. has four subsidiary companies in China:
1. Hunan Kangxin Biotechnology: for Microfludic FIA production.
2. Sichuan Vacure Prelab Biotechnology: for Microfludic DISKFLU production.
3. Hunan Narui New Material Technology: for Antibody, Antigen, Micorspheres production.
4. Henan VACURE Biotechnology: for RT-PCR and POCT PCR production.
CEleave a message
-
phone :
view details
-
address :
4th Floor, Building 7, Sanyi Innovation Center (Phase III), No. 733, Section 2, Furong Avenue, Wenjiang District, Chengdu, SiChuan Province, China.
-
postcode :
611100
-
website :
vacurebiotech.com